ArticleNPJ systems biology and applications2023

Knowledge-based mechanistic modeling accurately predicts disease progression with gefitinib in EGFR-mutant lung adenocarcinoma.

Adèle L'Hostis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.